The aim of this review is to provide an up-to-date overview of the Keap1/Nrf2 signaling pathway and its involvement in the development of main liver diseases such as alcoholic liver damage, viral liver diseases, steatosis, steatohepatitis, cholestatic damage, and liver cancer. This evidence concerns the gene NFE2L2 and liver disorder.